Are you a BC/BE non-invasive cardiologist passionate about quality and committed to excellence? We are looking for a physician to join our academic clinical practice faculty. Learn more at https://t.co/c7uYxPTJ1z
Bob Gibson, the St. Louis Cardinals’ Hall of Fame right-hander, has died at 84. He was one of baseball’s most dominating pitchers. https://t.co/dy5h3jhwnY
How does COVID-19 affect the heart? The debate over the disease's impact shows how, even though this coronavirus should be taken seriously, it’s not all that strange, writes @edyong209: https://t.co/6b4WZPC8AI
MVP with Mitral Annular Disjunction (MAD) in 43-yo female resuscitated for ventr. fibrillation.
MAD, leaflet redundancy & rest ECG changes, but not regurgitation severity, associated with severe arrhythmia in MVP (Essayagh et al https://t.co/IfYgePaTY9)
#cardiotwitter@escardio
Watching the Sopranos episode where Tony is in a coma, and the only thing I can focus on is the fact that T’s monitor has PA readings when he clearly doesn’t have a Swan in!
This is a great perspective on an excellent dietary pattern that our patients can actually achieve. Even if one falls short of 100% adherence, it could be the start of a meaningful change to decrease CV events that lasts a lifetime.
This #JACC review topic of the week summarizes diet and health, data from landmark clinical trials of the Mediterranean diet, and guidelines to support the hypothesis that a Pesco-Mediterranean diet is ideal for optimizing cardiovascular health. https://t.co/R2SpOv1KKC 🌿 🥜 🐟
The Cardiovascular Fellow's class of 2023 photo at the University of Nebraska Medical Center! I am honored to be apart of such an amazing group of physicians. @CvUnmc@unmc#MasksSaveLives
Yesterday, I had the luck of 3 great #echofirst TEEs. A degenerated bAVR with wide open AI and diastolic MR, classic rheumatic mitral valve disease with mod MR/MS, and a case of caseous necrosis of the posterior mitral annulus. Love training fellows like @swethika at @CvUnmc!
As @VPrasadMDMPH has pointed out, in the COVID19 era, we seem to eager to apply unproven tx to patients outside of proper research studies.
Let's not make that mistake again for cardiac MRI!
Elderly patients with AF who were not candidates for standard doses of oral anticoagulants because of a high risk of bleeding were assigned to receive 15 mg of edoxaban or placebo once daily. Edoxaban was superior to placebo in preventing stroke or systemic embolism. #ESCCongress
Thread: To me, the most stunning report from #ESCCongress thus far: RATE-AF trial
Older pts w/ permanent AF + shortness of breath. (there are lots of these pts).
Rate control is crucial
In 2020, most receive beta-blockers.
But BB can cause dyspnea.
What about dig?
Gulp! 1/
Effect of icosapent ethyl on progression of #coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial https://t.co/tTH9uXcsL5
#EHJ#ESCCongress#cardiotwitter